{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:47:02Z","timestamp":1783698422582,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is mounting evidence on the existence of a Pediatric Inflammatory Multisystem Syndrome-temporally associated to SARS-CoV-2 infection (PIMS-TS), sharing similarities with Kawasaki Disease (KD). The main outcome of the study were to better characterize the clinical features and the treatment response of PIMS-TS and to explore its relationship with KD determining whether KD and PIMS are two distinct entities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Rheumatology Study Group of the Italian Pediatric Society launched a survey to enroll patients diagnosed with KD (Kawasaki Disease Group \u2013 KDG) or KD-like (Kawacovid Group - KCG) disease between February 1st 2020, and May 31st 2020. Demographic, clinical, laboratory data, treatment information, and patients\u2019 outcome were collected in an online anonymized database (RedCAP\u00ae). Relationship between clinical presentation and SARS-CoV-2 infection was also taken into account. Moreover, clinical characteristics of KDG during SARS-CoV-2 epidemic (KDG-CoV2) were compared to Kawasaki Disease patients (KDG-Historical) seen in three different Italian tertiary pediatric hospitals (Institute for Maternal and Child Health, IRCCS \u201cBurlo Garofolo\u201d, Trieste; AOU Meyer, Florence; IRCCS Istituto Giannina Gaslini, Genoa) from January 1st 2000 to December 31st 2019. Chi square test or exact Fisher test and non-parametric Wilcoxon Mann-Whitney test were used to study differences between two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One-hundred-forty-nine cases were enrolled, (96 KDG and 53 KCG). KCG children were significantly older and presented more frequently from gastrointestinal and respiratory involvement. Cardiac involvement was more common in KCG, with 60,4% of patients with myocarditis. 37,8% of patients among KCG presented hypotension\/non-cardiogenic shock. Coronary artery abnormalities (CAA) were more common in the KDG. The risk of ICU admission were higher in KCG. Lymphopenia, higher CRP levels, elevated ferritin and troponin-T characterized KCG. KDG received more frequently immunoglobulins (IVIG) and acetylsalicylic acid (ASA) (81,3% vs 66%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04 and 71,9% vs 43,4%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001 respectively) as KCG more often received glucocorticoids (56,6% vs 14,6%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). SARS-CoV-2 assay more often resulted positive in KCG than in KDG (75,5% vs 20%; p\u2009&lt;\u20090.0001). Short-term follow data showed minor complications. Comparing KDG with a KD-Historical Italian cohort (598 patients), no statistical difference was found in terms of clinical manifestations and laboratory data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study suggests that SARS-CoV-2 infection might determine two distinct inflammatory diseases in children: KD and PIMS-TS. Older age at onset and clinical peculiarities like the occurrence of myocarditis characterize this multi-inflammatory syndrome. Our patients had an optimal response to treatments and a good outcome, with few complications and no deaths.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-021-00511-7","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T08:11:47Z","timestamp":1615882307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey"],"prefix":"10.1186","volume":"19","author":[{"name":"on behalf of the Rheumatology Study Group of the Italian Pediatric Society","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cattalini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Della Paolera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Zunica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bracaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Giangreco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Verdoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Meini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Sottile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Caorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianvincenzo","family":"Zuccotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Fabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Montin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Meneghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Consolaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Dellepiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"La Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Simonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6817-4953","authenticated-orcid":false,"given":"Andrea","family":"Taddio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"511_CR1","unstructured":"https:\/\/www-epicentro-iss-it.proxy.unibs.it\/coronavirus\/bollettino\/Infografica_10giugno ITA.pdf (Accessed 12 June 2020)."},{"key":"511_CR2","doi-asserted-by":"publisher","first-page":"2000600","DOI":"10.2807\/1560-7917.ES.2020.25.18.2000600","volume":"25","author":"S Garazzino","year":"2020","unstructured":"Garazzino S, Montagnani C, Don\u00e0 D, Meini A, Felici E, Vergine G, et al. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020. Euro Surveill. 2020;25:2000600.","journal-title":"Euro Surveill."},{"key":"511_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc2007617","volume":"383","author":"N Parri","year":"2020","unstructured":"Parri N, Lenge M, Buonsenso D. Coronavirus infection in pediatric emergency departments (CONFIDENCE) research group. Children with Covid-19 in pediatric emergency departments in Italy. N Engl J Med. 2020;383:187\u201390.","journal-title":"N Engl J Med"},{"key":"511_CR4","doi-asserted-by":"publisher","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","volume":"145","author":"Y Dong","year":"2020","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;145:e20200702.","journal-title":"Pediatrics"},{"key":"511_CR5","doi-asserted-by":"publisher","first-page":"e20201711","DOI":"10.1542\/peds.2020-1711","volume":"146","author":"F Licciardi","year":"2020","unstructured":"Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S, et al. SARS-CoV-2-induced Kawasaki-like Hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics. 2020;146:e20201711.","journal-title":"Pediatrics."},{"key":"511_CR6","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S2352-4642(20)30168-1","volume":"4","author":"A Wolfler","year":"2020","unstructured":"Wolfler A, Mannarino S, Giacomet V, Camporesi A, Zuccotti G. Acute myocardial injury: a novel clinical pattern in children with COVID-19. Lancet Child Adolesc Health. 2020;4:e26\u20137.","journal-title":"Lancet Child Adolesc Health"},{"key":"511_CR7","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395:1771\u20138.","journal-title":"Lancet."},{"key":"511_CR8","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607\u20138.","journal-title":"Lancet."},{"key":"511_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","volume":"324","author":"E Whittaker","year":"2020","unstructured":"Whittaker E, Bamford A, Kenny J, Kaforu M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324:259\u201369.","journal-title":"JAMA."},{"key":"511_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13613-020-00690-8","volume":"10","author":"M Grimaud","year":"2020","unstructured":"Grimaud M, Starck J, Levy M, Marais C, Chareyre C, Khraiche D, et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care. 2020;10:69.","journal-title":"Ann Intensive Care"},{"key":"511_CR11","unstructured":"Royal College of Pediatrics and Child Health. Guidance: Paediatric multisystem inflammatory syndrome temporally associated with COVID-19. https:\/\/www.rcpch.ac.uk\/sites\/default\/files\/2020-05\/COVID-19-Paediatric-multisystem-inflammatory syndrome-20200501.pdf (Accessed 8 May 2020)."},{"key":"511_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31094","volume-title":"Emergency Preparedness and Response Multisystem In ammatory Syndrome in Children ( MIS-C ) Associated with Coronavirus Disease 2019","author":"Centre for Disease Control and Prevention","year":"2020","unstructured":"Centre for Disease Control and Prevention. Emergency Preparedness and Response Multisystem In ammatory Syndrome in Children ( MIS-C ) Associated with Coronavirus Disease 2019; 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)31094."},{"key":"511_CR13","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term Management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association [published correction appears in circulation. 2019 Jul 30; 140: e181-e184]. Circulation. 2017;135:e927\u201399.","journal-title":"Circulation."},{"key":"511_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"511_CR15","doi-asserted-by":"publisher","first-page":"2001010","DOI":"10.2807\/1560-7917.ES.2020.25.22.2001010","volume":"25","author":"A Belot","year":"2020","unstructured":"Belot A, Antona D, Renolleau S, Javouhey E, Hentgen V, Angoulvant F, et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill. 2020;25:2001010.","journal-title":"Euro Surveill"},{"key":"511_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/annrheumdis-2020-217960","volume":"79","author":"M Pouletty","year":"2020","unstructured":"Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. 2020;79:999\u20131006.","journal-title":"Ann Rheum Dis"},{"key":"511_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347\u201358.","journal-title":"N Engl J Med"},{"key":"511_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334\u201346.","journal-title":"N Engl J Med"},{"key":"511_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MPH.0000000000000872","volume":"39","author":"S Garc\u00eda-Pav\u00f3n","year":"2017","unstructured":"Garc\u00eda-Pav\u00f3n S, Yamazaki-Nakashimada MA, B\u00e1ez M, Borjas-Aguilar KL, Murata C. Kawasaki disease complicated with macrophage activation syndrome: a systematic review. J Pediatr Hematol Oncol. 2017;39:445\u201351.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"20","key":"511_CR20","doi-asserted-by":"publisher","first-page":"30215","DOI":"10.1016\/S2352-4642(20)30215-7","volume":"S2352\u20134642","author":"P Davies","year":"2020","unstructured":"Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierly J, Waters G, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;S2352\u20134642(20):30215\u20137. https:\/\/doi.org\/10.1016\/S2352-4642(20)30215-7.","journal-title":"Lancet Child Adolesc Health"},{"key":"511_CR21","doi-asserted-by":"publisher","unstructured":"Navarro-Mill\u00e1n I, Sattui SE, Lakhanpal A, Zisa D, Siegel CH, Crow MK. Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series. Arthritis Rheumatol. 2020. https:\/\/doi.org\/10.1002\/art.41422.","DOI":"10.1002\/art.41422"},{"key":"511_CR22","doi-asserted-by":"publisher","unstructured":"Belhadjer Z, M\u00e9ot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048360.","DOI":"10.1161\/CIRCULATIONAHA.120.048360"},{"key":"511_CR23","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","volume":"369","author":"J Toubiana","year":"2020","unstructured":"Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094 Published 2020 Jun 3.","journal-title":"BMJ"},{"key":"511_CR24","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00431-017-2947-3","volume":"176","author":"R Cimaz","year":"2017","unstructured":"Cimaz R, Fanti E, Mauro A, Voller F, Rusconi F. Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records. Eur J Pediatr. 2017;176:1061\u20135.","journal-title":"Eur J Pediatr"},{"key":"511_CR25","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1136\/annrheumdis-2020-218110","volume":"79","author":"A Ravelli","year":"2020","unstructured":"Ravelli A, Martini A. Kawasaki disease or Kawasaki syndrome? Ann Rheum Dis. 2020;79:993\u20135.","journal-title":"Ann Rheum Dis"},{"key":"511_CR26","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1542\/peds.2008-1871","volume":"123","author":"JT Kanegaye","year":"2009","unstructured":"Kanegaye JT, Wilder MS, Molkara D, Frazer JR, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009;123:e783\u20139.","journal-title":"Pediatrics."},{"key":"511_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10067-016-3316-8","volume":"36","author":"A Taddio","year":"2017","unstructured":"Taddio A, Rossi ED, Monasta L, Pastore S, Tommasini A, Lepore L, et al. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Clin Rheumatol. 2017;36:223\u20138.","journal-title":"Clin Rheumatol"},{"key":"511_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1542\/hpeds.2020-0123","volume":"10","author":"VG Jones","year":"2020","unstructured":"Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020;10:537\u201340.","journal-title":"Hosp Pediatr"},{"key":"511_CR29","doi-asserted-by":"publisher","unstructured":"[No author] Best available treatment study for inflammatory conditions associated with COVID-19. https:\/\/doi.org\/10.1186\/ISRCTN69546370.","DOI":"10.1186\/ISRCTN69546370"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-021-00511-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T08:25:01Z","timestamp":1615883101000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-021-00511-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1186\/s12969-021-00511-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-106975\/v1","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"10 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval and consent to participate was achieved (IRCCS Burlo Garofolo-03\/2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AR has received grant support and\/or speaking or consultant fees from AbbVie, Angelini, Bristol-Myers Squibb, Novartis, Pfizer, Reckitt-Benkiser, Roche and Johnson & Johnson; MC, SDP, FZ, CB, LV, AM, RS, RC, GZ, MF, DM, AM, AC, RMD, MCM, FLT, AM, GS, AV, RC and AT do not have any conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}